Saltar al contenido
Merck

Night blindness and the mechanism of constitutive signaling of mutant G90D rhodopsin.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2008-11-07)
Alexander M Dizhoor, Michael L Woodruff, Elena V Olshevskaya, Marianne C Cilluffo, M Carter Cornwall, Paul A Sieving, Gordon L Fain
RESUMEN

The G90D rhodopsin mutation is known to produce congenital night blindness in humans. This mutation produces a similar condition in mice, because rods of animals heterozygous (D+) or homozygous (D+/+) for this mutation have decreased dark current and sensitivity, reduced Ca(2+), and accelerated values of tau(REC) and tau(D), similar to light-adapted wild-type (WT) rods. Our experiments indicate that G90D pigment activates the cascade, producing an equivalent background light of approximately 130 Rh* rod(-1) for D+ and 890 Rh* rod(-1) for D+/+. The active species of the G90D pigment could be unregenerated G90D opsin or G90D rhodopsin, either spontaneously activated (as Rh*) or in some other form. Addition of 11-cis-retinal in lipid vesicles, which produces regeneration of both WT and G90D opsin in intact rods and ROS membranes, had no effect on the waveform or sensitivity of dark-adapted G90D responses, indicating that the active species is not G90D opsin. The noise spectra of dark-adapted G90D and WT rods are similar, and the G90D noise variance is much less than of a WT rod exposed to background light of about the same intensity as the G90D equivalent light, indicating that Rh* is not the active species. We hypothesize that G90D rhodopsin undergoes spontaneous changes in molecular conformation which activate the transduction cascade with low gain. Our experiments provide the first indication that a mutant form of the rhodopsin molecule bound to its 11-cis-chromophore can stimulate the visual cascade spontaneously at a rate large enough to produce visual dysfunction.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
L-α-fosfatidilcolina, egg yolk, Type XI-E, 100 mg/mL in chloroform, ≥99%, solution